加拿大结直肠癌发病率与死亡率按年龄、部位及组织学分析
该研究基于加拿大癌症登记和生命统计死亡数据库,分析1992至2019年结直肠癌发病率及1974至2022年死亡率。结果显示,55岁以下人群结直肠癌发病率稳定或上升,50-54岁人群发病率未下降;20-49岁人群死亡率在1990年代末停止下降;直肠癌死亡率上升。建议筛查项目关注50-54岁人群。
要点
- 55岁以下人群结直肠癌发病率稳定或上升,50-54岁人群未下降。
- 20-49岁人群结直肠癌死亡率在1990年代末停止下降。
- 直肠癌死亡率上升,近端和远端结直肠癌死亡率下降。
核心结论
- 加拿大结直肠癌发病率和死亡率因年龄、部位和组织学而异。
- 除降低筛查起始年龄外,筛查项目应关注50-54岁人群,因其结直肠癌发病率未下降。
研究设计与样本
- 使用加拿大癌症登记和加拿大生命统计死亡数据库。
- 发病率数据为1992年至2019年,死亡率数据为1974年至2022年。
- 采用Joinpoint回归计算年度百分比变化,并使用样条年龄-时期-队列模型。
主要发现
- 20-29岁人群结直肠癌发病率稳定,30-49岁上升,50-54岁稳定,55岁及以上下降。
- 55岁以下人群近端、远端和直肠癌发病率稳定或上升,55岁以上下降。
- 55岁以下腺癌发病率上升,所有年龄黏液性和印戒细胞癌发病率下降或稳定,神经内分泌癌在多数年龄上升。
- 20-49岁人群结直肠癌死亡率在1990年代末停止下降,50岁以上下降。
- 近端和远端结直肠癌死亡率在所有年龄下降,直肠癌死亡率上升。
临床怎么用
- 结直肠癌筛查项目应考虑降低筛查起始年龄。
- 筛查项目应重点关注50-54岁人群,因其结直肠癌发病率未下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Colorectal cancer (CRC) incidence is increasing among younger individuals in many countries. We examined CRC incidence and mortality by age group, site, and histology in Canada. METHODS: Data from the Canadian Cancer Registry and the Canadian Vital Statistics Death Database were used to determine CRC incidence from 1992 to 2019 and mortality from 1974 to 2022. We calculated incidence by age group, site, and histology and mortality by age group and site. Annual percent change was calculated using Joinpoint Regression. Age-period-cohort models with splines were run to indicate influence on CRC incidence. RESULTS: CRC incidence was stable for individuals 20-29 years, increased for those 30-49, remained stable for 50-54, and decreased for 55 years and older. Proximal, distal, and rectal cancer incidence was stable or increased for individuals less than 55 and decreased for those over 55. Adenocarcinoma CRCs increased for those less than 55. Mucinous and signet ring cell CRCs decreased or remained stable for all ages. Neuroendocrine CRCs increased for most ages. Age, cohort, and period effects are evident. CRC mortality stopped decreasing in the late 1990s for individuals 20-49 but decreased for those over 50. Proximal and distal CRC mortality decreased for all ages. Rectal cancer mortality increased. DISCUSSION: CRC incidence and mortality in Canada vary by age, site, and histology. In addition to a reduction in the screening start age, CRC screening programs must focus on individuals 50-54 years of age because they have not experienced a decrease in CRC incidence.
引用
- Decker KM, Lambert P, Bravo J, et al. Colorectal Cancer Incidence and Mortality by Age Group, Colon Location, and Histology in Canada. Am J Gastroenterol. 2026. PMID: 42479594. doi:10.14309/ajg.0000000000004141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。